Obesity Epidemiology

GENETIC PREDICTORS OF OBESITY 45765. Durand E, Boutin P, Meyre D, et al. Polymorphisms in the amino acid transportersolute carrier family 6 (neurotransmitter transporter) member 14 gene contribute topolygenic obesity in French Caucasians. Diabetes. 2004;53:2483-2486.66. Newton-Cheh C, Hirschhorn JN. Genetic association studies of complex traits: designand analysis issues. Mutat Res. 2005;573:54-69.67. Neale BM, Sham PC. The future of association studies: gene-based analysis andreplication. Am J Hum Genet. 2004;75:353-362.68. International HapMap Consortium. A haplotype map of the human genome. Nature.2005;437:1299-1320.69. de Bakker PI, Yelensky R, Pe’er I, Gabriel SB, Daly MJ, Altshuler D. Efficiency andpower in genetic association studies. Nat Genet. 2005;37:1217-1223.70. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA. Selecting amaximally informative set of single-nucleotide polymorphisms for association analysesusing linkage disequilibrium. Am J Hum Genet. 2004;74:106-120.71. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium:the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J HumGenet. 1993;52:506-516.72. Krief S, Lonnqvist F, Raimbault S, et al. Tissue distribution of beta 3-adrenergicreceptor mRNA in man. J Clin Invest. 1993;91:344-349.73. Clement K, Vaisse C, Manning, B St. J., et al. Genetic variation in the beta3-adrenergicreceptor and an increased capacity to gain weight in patients with morbid obesity.N Engl J Med. 1995;333:352-354.74. Kadowaki H, Yasuda K, Iwamoto K, et al. A mutation in the beta 3-adrenergicreceptor gene is associated with obesity and hyperinsulinemia in Japanese subjects.Biochem Biophys Res Commun. 1995;215:555-560.75. Widen E, Lehto M, Kanninen T, Walston J, Shuldiner AR, Groop LC. Association ofa polymorphism in the beta 3-adrenergic-receptor gene with features of the insulinresistance syndrome in Finns. N Engl J Med. 1995;10:348-351.76. Allison DB, Heo M, Faith MS, Pietrobelli A. Meta-analysis of the association of theTrp64Arg polymorphism in the beta3 adrenergic receptor with body mass index. IntJ Obes Relat Metab Disord. 1998;22:559-566.77. Fujisawa T, Ikegami H, Kawaguchi Y, Ogihara T. Meta-analysis of the association ofTrp64Arg polymorphism of beta 3-adrenergic receptor gene with body mass index.J Clin Endocrinol Metab. 1998;83:2441-2444.78. Kurokawa N, Nakai K, Kameo S, Liu ZM, Satoh H. Association of BMI with thebeta3-adrenergic receptor gene polymorphism in Japanese: meta-analysis. Obes Res.2001;9:741-745.79. Oizumi T, Daimon M, Saitoh T, et al. Genotype Arg/Arg, but not Trp/Arg, of theTrp64Arg polymorphism of the beta(3)-adrenergic receptor is associated with type 2diabetes and obesity in a large Japanese sample. Diabetes Care. 2001;24:1579-1583.80. Matsushita Y, Yokoyama T, Yoshiike N, et al. The Trp(64)Arg polymorphism of thebeta(3)-adrenergic receptor gene is not associated with body weight or body mass indexin Japanese: a longitudinal analysis. J Clin Endocrinol Metab. 2003;88:5914-5920.81. Berger J, Moller DE. The mechanisms of action of PPARs. Annu Rev Med.2002;53:409-435.82. Ristow M, Muller-Wieland D, Pfeiffer A, Krone W, Kahn CR. Obesity associatedwith a mutation in a genetic regulator of adipocyte differentiation. N Engl J Med.1998;339:953-959.83. Stumvoll M, Haring H. The peroxisome proliferator-activated receptor-gamma2Pro12Ala polymorphism. Diabetes. 2002;51:2341-2347.84. Altshuler D, Hirschhorn JN, Klannemark M, et al. The common PPARgamma Pro12-Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet.2000;26:76-80.